跳至主要内容
临床试验/NCT02894749
NCT02894749已完成不适用

Evaluation of 3D Rotational Angiography After EVAR

University Hospital, Lille1 个研究点 分布在 1 个国家目标入组 427 人开始时间: 2015年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
427
试验地点
1
主要终点
Effective Dose

研究概览

简要总结

This is a randomized prospective monocentric study to evaluate the benefits of a 3D rotational acquisition (3DRA) to assess technical success after treatment of infra-renal aneurysm with bifurcated endograft. Patients will be randomized between the standard strategy (2D angiography at the end of the procedure and angioCT-scan before discharge) and the new strategy (3DRA at the end of the procedure). Expected findings are a reduction of radiation exposure and contrast medium used during the hospital stay, with a similar resolution between angioCT-scan and 3DRA to depict the main complications after EVAR (occlusion, kinking, endoleak). Furthermore, any complication depicted after 3DRA group could benefit from an additional procedure during the same operating time, and therefore avoid a second intervention for the patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients treated with EVAR for infra-renal aortic aneurysm
  • In a hybrid room
  • With a signed consent

排除标准

  • Pregnant women
  • Patients unable to understand the study protocol or to give their consents
  • Renal insufficiency (eGFR<60mL/min)
  • Ruptured aneurysms and other emergency settings

研究组 & 干预措施

3D rotational angiography (3DRA)

Experimental

New strategy - Patients benefit from a 3D rotational acquisition at the end of procedure, which offers CT-like reconstructions. If any technical issues is depicted on the 3DRA, it can be treated during the same operating time. A contrast-enhanced ultrasound is performed for each patient before discharge to confirm that no technical issue was missed by the 3DRA.

干预措施: 3D rotational angiography (3DRA) (Radiation)

2D Angiography (2DA)

No Intervention

Standard of care - Patients benefit from a 2D completion angiogram at the end of the procedure, and from a angioCT-scan before discharge. If any technical issues is depicted on the CT-scan, a new intervention needs to be scheduled.

结局指标

主要结局

Effective Dose

时间窗: Single 1 day - At patient discharge

Total exposure to radiation in mSv

次要结局

  • Reintervention rate(During the first 30 days)
  • Contrast Medium(Single 1 day - At patient discharge)
  • Additional procedure(During surgery)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验